1,181
Views
29
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Quality and Outcomes of Treatment of Hypercalcemia of Malignancy

, , , , , , , & show all
Pages 331-339 | Received 10 Jan 2015, Accepted 29 Apr 2015, Published online: 12 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Uri Abadi, Lee Peled, Ronit Gurion, Pnina Rotman-Pikielny, Pia Raanani, Martin H. Ellis & Uri Rozovski. (2019) Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma. Leukemia & Lymphoma 60:12, pages 2922-2926.
Read now
Alan C Dalkin & Mitchell H Rosner. (2015) Denosumab in the treatment of hypercalcemia secondary to malignancy. Orphan Drugs: Research and Reviews 5, pages 113-121.
Read now

Articles from other publishers (27)

Lorenzo Scappaticcio, Arif Nur Muhammad Ansori & Pierpaolo Trimboli. (2023) Editorial: Cancer-related hypercalcemia and potential treatments. Frontiers in Endocrinology 14.
Crossref
Johnathan Yao, Madison Novosel, Shreya Bellampalli, Jennifer Kapo, Julia Joseph & Elizabeth Prsic. (2023) Lung Cancer Supportive Care and Symptom Management. Hematology/Oncology Clinics of North America 37:3, pages 609-622.
Crossref
Elvina Almuradova & Irfan Cicin. (2023) Cancer-related hypercalcemia and potential treatments. Frontiers in Endocrinology 14.
Crossref
Xuhua Xia, Jie Cao, Chunli Long, Xin Chen & Jiajia Zheng. (2023) Clinical characteristics of hypercalcemic crises in a tertiary children’s hospital. Endocrine 81:1, pages 175-181.
Crossref
Ghada El-Hajj Fuleihan, Gregory A Clines, Mimi I Hu, Claudio Marcocci, M Hassan Murad, Thomas Piggott, Catherine Van Poznak, Joy Y Wu & Matthew T Drake. (2023) Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism 108:3, pages 507-528.
Crossref
Priyanka Majety, Anna Groysman, Natanie Erlikh, Zsu Zsu Chen & Gregory P. Westcott. (2022) Predictors of Mortality in Hypercalcemia of Advanced Chronic Liver Disease. Endocrine Practice 28:10, pages 1062-1068.
Crossref
Michael C. Onyema, Eftychia E. Drakou & Georgios K. Dimitriadis. (2022) Endocrine abnormality in paraneoplastic syndrome. Best Practice & Research Clinical Endocrinology & Metabolism 36:3, pages 101621.
Crossref
Theresa A. GuiseJohn J. Wysolmerski. (2022) Cancer-Associated Hypercalcemia. New England Journal of Medicine 386:15, pages 1443-1451.
Crossref
Marlene Chakhtoura & Ghada El-Hajj Fuleihan. (2021) Treatment of Hypercalcemia of Malignancy. Endocrinology and Metabolism Clinics of North America 50:4, pages 781-792.
Crossref
Aya Bassatne, Maya Rahme, Thomas Piggott, M. Hassan Murad, Layal Hneiny & Ghada El-Hajj Fuleihan. (2021) Values and other decisional factors regarding treatment of hypercalcaemia of malignancy: a systematic review protocol. BMJ Open 11:10, pages e051141.
Crossref
Elena Chertok Shacham, Dafna Chap Marshak, Shay Brikman, Guy Dori & Avraham Ishay. (2021) Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma. Medicine 100:14, pages e24982.
Crossref
Michael T. Sheehan, Robert A. Wermers, Aminah Jatoi, Charles L. Loprinzi & Adedayo A. Onitilo. (2020) Oral cinacalcet responsiveness in non-parathyroid hormone mediated hypercalcemia of malignancy. Medical Hypotheses 143, pages 110149.
Crossref
Attiya A. Khan, Payal K. Gurnani, Gary D. Peksa, William L. Whittier & Joshua M. DeMott. (2020) Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy. Annals of Pharmacotherapy, pages 106002802095704.
Crossref
Brian A Hain, Baptiste Jude, Haifang Xu, Dallas M Smuin, Edward J Fox, John C Elfar & David L Waning. (2019) Zoledronic Acid Improves Muscle Function in Healthy Mice Treated with Chemotherapy. Journal of Bone and Mineral Research 35:2, pages 368-381.
Crossref
Anery Patel, Laura Graeff-Armas, Meredith Ross & Whitney Goldner. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 565 571.e1 .
Mickael Essouma, Dorothée M. Soh, Mazou N. Temgoua, Ronald M. Gobina, Aristide T. Nono, Etienne Olivier Atenguena, Mahamat Maimouna & Gloria E. Ashuntantang. (2019) Adult T-type lymphoblastic lymphoma presenting as hypercalcemic crisis and aplastic anemia: a case report. Journal of Medical Case Reports 13:1.
Crossref
Shruti Bhandari, Rohit Kumar, Prashant Tripathi, Abigail Chan, Sarah Mudra & Rebecca Redman. (2019) Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis. Medical Oncology 36:10.
Crossref
Da Eun Shin, Seol Hee Park, Sung Hwan Kim, Sung Yun Suh, Yun Hee Jo, Yoon Sook Cho, Seock-Ah Im & Ju-Yeun Lee. (2019) Real-world Treatment Pattern and Outcomes of Hypercalcemia among Solid Tumor Patients. Korean Journal of Clinical Pharmacy 29:3, pages 166-172.
Crossref
James C. Cripe, Tommy R. Buchanan Jr, Leping Wan, Andrea R. Hagemann, Carolyn K. McCourt, L. Stewart Massad, Katherine C. Fuh, David G. Mutch, Mathew A. Powell, Premal H. Thaker & Lindsay M. Kuroki. (2019) Inpatient management of hypercalcemia portends a poor prognosis among gynecologic oncology patients: A trigger to initiate hospice care?. Gynecologic Oncology Reports 28, pages 1-5.
Crossref
Adam S. Levin, Sara R. Alcorn, Brian J. Neuman & Christian F. Meyer. (2019) Team Approach: Emergencies in Patients with Skeletal Metastases. JBJS Reviews 7:3, pages e8-e8.
Crossref
Kelly Plach, Randall W. Knoebel, Rita Nanda & Katherine Shea. (2017) Retrospective chart evaluation of hypercalcemia management in oncology patients at the University of Chicago Medical Center. Journal of Oncology Pharmacy Practice 25:2, pages 317-325.
Crossref
Jonathan Zagzag, Mimi I. Hu, Sarah B. Fisher & Nancy D. Perrier. (2018) Hypercalcemia and cancer: Differential diagnosis and treatment. CA: A Cancer Journal for Clinicians 68:5, pages 377-386.
Crossref
S. Krug & P. Michl. (2017) Metabolische Entgleisungen als paraneoplastische SyndromeMetabolic disorders as paraneoplastic syndromes. Der Internist 59:2, pages 114-124.
Crossref
Juan C Osorio, Masha G Jones, Nina Schatz-Siemers & Stephanie J Tang. (2017) Twist on a classic: vitamin D and hypercalcaemia of malignancy. BMJ Case Reports, pages bcr-2017-220819.
Crossref
Katsushi Takeda, Ryosuke Kimura, Nobuhiro Nishigaki, Shinya Sato, Asami Okamoto, Kumiko Watanabe & Sachie Yasui. (2017) Humoral Hypercalcemia of Malignancy with a Parathyroid Hormone-Related Peptide-Secreting Intrahepatic Cholangiocarcinoma Accompanied by a Gastric Cancer. Case Reports in Endocrinology 2017, pages 1-6.
Crossref
Lindsay L. Graves, Susan V. Bukata, Nona Aghazadehsanai, Tina I. Chang, Neal R. Garrett & Arthur H. Friedlander. (2016) Patients Receiving Parenteral Bisphosphonates for Malignant Disease and Having Developed an Atypical Femoral Fracture Are at Risk of Concomitant Osteonecrosis of the Jaw: An Evidence-Based Review. Journal of Oral and Maxillofacial Surgery 74:12, pages 2403-2408.
Crossref
Whitney Goldner. (2016) Cancer-Related Hypercalcemia. Journal of Oncology Practice 12:5, pages 426-432.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.